EDGAR Filing Documents for 0001104659-07-053426

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-07-053426

Filing Date

2007-07-11

Accepted

2007-07-11 20:23:21

Documents

Period of Report

2007-07-10

Document Format Files

Seq	Description	Document	Type	Size
1	4	a4.html	4
1	4	a4.xml	4	8353
	Complete submission text file	0001104659-07-053426.txt		10955

Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139

Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500

GENZYME CORP (Reporting) CIK: 0000732485 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31787 | Film No.: 07975141
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154

Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700

BIOENVISION INC (Issuer) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02042

Business Address 500 KENDALL STREET CAMBRIDGE MA 02042 617-252-7500

Wichita Bio CORP (Reporting) CIK: 0001402396 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31787 | Film No.: 07975140